project id: TCGA-HNSC; case submitter id: TCGA-P3-A6T2; source center: 23; state: released; a260 a280 ratio: 1.96; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.63; rna integrity number: 8.9; age at index: 45; days to birth: -16588; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1963; age at diagnosis: 16588; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2298.0; icd 10 code: C06.0; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cheek mucosa; synchronous malignancy: No; tissue or organ of origin: Cheek mucosa; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Yes; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 1912; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-P3-A6T2-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 55.0; percent tumor cells: 40.0; percent tumor nuclei: 60.0;